Descriptor English: | beta-N-Acetylhexosaminidases | ||||||
Descriptor Spanish: |
beta-N-Acetilhexosaminidasas
| ||||||
Descriptor Portuguese: | beta-N-Acetil-Hexosaminidases | ||||||
Descriptor French: | beta-N-Acetylhexosaminidases | ||||||
Entry term(s): |
N Acetyl beta D hexosaminidase N-Acetyl-beta-D-hexosaminidase beta Hexosaminidase beta N Acetyl D hexosaminidase beta N Acetyl hexosaminidase beta N Acetylhexosaminidase beta N Acetylhexosaminidases beta-Hexosaminidase beta-N-Acetyl-D-hexosaminidase beta-N-Acetyl-hexosaminidase beta-N-Acetylhexosaminidase |
||||||
Tree number(s): |
D08.811.277.450.483.180 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D001619 | ||||||
Scope note: | A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. |
||||||
Annotation: | do not confuse with ACETYLGLUCOSAMINIDASE; /defic: consider also TAY SACHS DISEASE and SANDHOFF DISEASE |
||||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Registry Number: | EC 3.2.1.52 | ||||||
CAS Type 1 Name: | beta-N-Acetyl-D-hexosaminide N-acetylhexosaminohydrolase | ||||||
Previous Indexing: |
Glycoside Hydrolases (1966-1970) Hexosaminidases (1971-1986) |
||||||
Public MeSH Note: | 2008; see BETA-N-ACETYL-D-HEXOSAMINIDASE 1988-2007 |
||||||
History Note: | 2008(1988) |
||||||
Related: |
Sandhoff Disease
MeSH Tay-Sachs Disease MeSH | ||||||
DeCS ID: | 19087 | ||||||
Unique ID: | D001619 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1987/01/01 | ||||||
Date of Entry: | 1986/06/02 | ||||||
Revision Date: | 2007/07/09 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes
|
beta-N-Acetylhexosaminidases
- Preferred
Concept UI |
M0002423 |
Scope note | A hexosaminidase specific for non-reducing N-acetyl-D-hexosamine residues in N-acetyl-beta-D-hexosaminides. It acts on GLUCOSIDES; GALACTOSIDES; and several OLIGOSACCHARIDES. Two specific mammalian isoenzymes of beta-N-acetylhexoaminidase are referred to as HEXOSAMINIDASE A and HEXOSAMINIDASE B. Deficiency of the type A isoenzyme causes TAY-SACHS DISEASE, while deficiency of both A and B isozymes causes SANDHOFF DISEASE. The enzyme has also been used as a tumor marker to distinguish between malignant and benign disease. |
Preferred term | beta-N-Acetylhexosaminidases |
Entry term(s) |
N Acetyl beta D hexosaminidase N-Acetyl-beta-D-hexosaminidase beta Hexosaminidase beta N Acetyl D hexosaminidase beta N Acetyl hexosaminidase beta N Acetylhexosaminidase beta N Acetylhexosaminidases beta-Hexosaminidase beta-N-Acetyl-D-hexosaminidase beta-N-Acetyl-hexosaminidase beta-N-Acetylhexosaminidase |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey